These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22004348)

  • 1. Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models.
    Lee ST; Chu K; Park JE; Jung KH; Jeon D; Lim JY; Lee SK; Kim M; Roh JK
    J Neurochem; 2012 Jan; 120(1):115-24. PubMed ID: 22004348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of erythropoietin in regulating angiogenesis.
    Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
    Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
    Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
    J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice.
    Adamcio B; Sperling S; Hagemeyer N; Walkinshaw G; Ehrenreich H
    Behav Brain Res; 2010 Mar; 208(1):80-4. PubMed ID: 19900484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
    Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
    Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease.
    Wang P; Xie ZH; Guo YJ; Zhao CP; Jiang H; Song Y; Zhu ZY; Lai C; Xu SL; Bi JZ
    Biochem Biophys Res Commun; 2011 Aug; 411(3):620-6. PubMed ID: 21771586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
    Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
    J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
    Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
    Scullion GA; Kendall DA; Marsden CA; Sunter D; Pardon MC
    Neuropharmacology; 2011; 60(2-3):223-34. PubMed ID: 20850464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease.
    Schultheiss C; Blechert B; Gaertner FC; Drecoll E; Mueller J; Weber GF; Drzezga A; Essler M
    Angiogenesis; 2006; 9(2):59-65. PubMed ID: 16821113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.